Trial · NCT03155997
Adverse events848
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
21 to 40 of 848
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Vision blurred | Eye disorders | 150 mg Abemaciclib + Endocrine Therapy | 46 | 2,791 | 52 |
| other | Vision blurred | Eye disorders | Endocrine Therapy | 24 | 2,800 | 25 |
| other | Abdominal distension | Gastrointestinal disorders | 150 mg Abemaciclib + Endocrine Therapy | 75 | 2,791 | 90 |
| other | Abdominal distension | Gastrointestinal disorders | Endocrine Therapy | 27 | 2,800 | 28 |
| other | Abdominal pain | Gastrointestinal disorders | 150 mg Abemaciclib + Endocrine Therapy | 945 | 2,791 | 1,974 |
| other | Abdominal pain | Gastrointestinal disorders | Endocrine Therapy | 226 | 2,800 | 275 |
| other | Constipation | Gastrointestinal disorders | 150 mg Abemaciclib + Endocrine Therapy | 288 | 2,791 | 377 |
| other | Constipation | Gastrointestinal disorders | Endocrine Therapy | 142 | 2,800 | 161 |
| other | Diarrhoea | Gastrointestinal disorders | 150 mg Abemaciclib + Endocrine Therapy | 2,294 | 2,791 | 11,663 |
| other | Diarrhoea | Gastrointestinal disorders | Endocrine Therapy | 199 | 2,800 | 288 |
| other | Dry mouth | Gastrointestinal disorders | 150 mg Abemaciclib + Endocrine Therapy | 94 | 2,791 | 103 |
| other | Dry mouth | Gastrointestinal disorders | Endocrine Therapy | 25 | 2,800 | 27 |
| other | Dyspepsia | Gastrointestinal disorders | 150 mg Abemaciclib + Endocrine Therapy | 205 | 2,791 | 264 |
| other | Dyspepsia | Gastrointestinal disorders | Endocrine Therapy | 61 | 2,800 | 66 |
| other | Flatulence | Gastrointestinal disorders | 150 mg Abemaciclib + Endocrine Therapy | 84 | 2,791 | 95 |
| other | Flatulence | Gastrointestinal disorders | Endocrine Therapy | 11 | 2,800 | 12 |
| other | Gastritis | Gastrointestinal disorders | 150 mg Abemaciclib + Endocrine Therapy | 58 | 2,791 | 65 |
| other | Gastritis | Gastrointestinal disorders | Endocrine Therapy | 31 | 2,800 | 34 |
| other | Gastrooesophageal reflux disease | Gastrointestinal disorders | 150 mg Abemaciclib + Endocrine Therapy | 74 | 2,791 | 76 |
| other | Gastrooesophageal reflux disease | Gastrointestinal disorders | Endocrine Therapy | 45 | 2,800 | 47 |
Source ClinicalTrials.govtrials-2026-11-12-0.4.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNone stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03155997/events?page=2